In the lungs, LPS recognition by Toll-like receptor 4 (TLR4) on bronchial epithelial cells and lung macrophages contributes to acute lung injury (ALI) and triggers innate immune responses, the release of inflammatory mediators, and activation of the NF-κB pathway [37]. Here, NFKB1 is linked to acute lung injury.